Exposure to Novel Parainfluenza Virus and Clinical Relevance in 2 Bottlenose Dolphin (Tursiops truncatus) Populations
Open Access
- 1 March 2008
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 14 (3) , 397-405
Abstract
Parainfluenza virus (PIV) is a leading cause of respiratory infections in humans. A novel virus closely related to human and bovine parainfluenza viruses types 3 (HPIV-3 and BPIV-3), named Tursiops truncatus parainfluenza virus type 1 (TtPIV-1), was isolated from a dolphin with respiratory disease. We developed a dolphin-specific ELISA to measure acute- and convalescent-phase PIV antibodies in dolphins during 1999–2006 with hemograms similar to that of the positive control. PIV seroconversion occurred concurrently with an abnormal hemogram in 22 animals, of which 7 (31.8%) had respiratory signs. Seroprevalence surveys were conducted on 114 healthy bottlenose dolphins in Florida and California. When the most conservative interpretation of positive was used, 11.4% of healthy dolphins were antibody positive, 29.8% were negative, and 58.8% were inconclusive. PIV appears to be a common marine mammal virus that may be of human health interest because of the similarity of TtPIV-1 to BPIV-3 and HPIV-3.Keywords
This publication has 34 references indexed in Scilit:
- Characterization of a parainfluenza virus isolated from a bottlenose dolphin (Tursiops truncatus)Veterinary Microbiology, 2008
- Bottlenose Dolphins as Marine Ecosystem Sentinels: Developing a Health Monitoring SystemEcohealth, 2004
- Respiratory viruses predisposing to bacterial infections: role of neuraminidaseThe Pediatric Infectious Disease Journal, 2004
- Parainfluenza VirusesClinical Microbiology Reviews, 2003
- Antibody Responses to Bovine Parainfluenza Virus Type 3 (PIV3) Vaccination and Human PIV3 Infection in Young InfantsThe Journal of Infectious Diseases, 2001
- Parainfluenza Virus 3 Infection after Stem Cell Transplant: Relevance to Outcome of Rapid Diagnosis and Ribavirin TreatmentClinical Infectious Diseases, 2001
- Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infantsThe Pediatric Infectious Disease Journal, 1996
- A Live Attenuated Bovine Parainfluenza Virus Type 3 Vaccine Is Safe, Infectious, Immunogenic, and Phenotypically Stable in Infants and ChildrenThe Journal of Infectious Diseases, 1995
- Attenuation of Bovine Parainfluenza Virus Type 3 in Nonhuman Primates and Its Ability to Confer Immunity to Human Parainfluenza Virus Type 3 ChallengeThe Journal of Infectious Diseases, 1988
- A study of dogs with kennel coughVeterinary Record, 1978